Translation and Reliability of FAAM-U

This study is designed to translate and validate the FAAM questionnaire to the Urdu language, to interpret its psychometric properties, and to determine the reliability of scores obtained from the population of Pakistan. The translated version of the gold standard tool will be used by the local population as well as Urdu-speaking immigrants across the globe to better understand and report the severity of their symptoms. Hence, to improve quality of life across cultures, there is a need of standard outcome measures in Urdu language.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Foot Injuries Ankle Injuries Leg Injuries Wounds and Injuries

Age range

16 year–44 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The University of Lahore

Lahore, Punjab Province, 54000, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ankle and foot disorders, referred by a general physician or surgeon,
Conscious
Ambulatory
Able to write and read Urdu language

Exclusion criteria

inflammatory disease
vascular diseases
neural diseases
cancer

Treatment and study plan

FAAM

Other

The FAAM is made out of two subscales including ADL and Sports subscales that have a complete score of 84 and 32, individually

Primary outcomes

FAAM-U

Time frame: 72 Hours

The FAAM is made out of two subscales including ADL and Sports subscales that have a complete score of 84 and 32, individually. Also, toward the finish of the structure, patients were approached to rate the current degree of function with a 4-point Likert scale

Sponsors and collaborators

Lead sponsor

University of Lahore

Other

Registry information

Official study title

Translation, Cross-Cultural Adaptation and Reliability of Urdu Version of The Foot and Ankle Ability Measures (FAAM-U)

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Aug 18, 2023
Registry last updated: Aug 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed